Literature DB >> 24506802

Psychotropic medication characteristics for special education students with emotional and/or behavioral disorders.

Richard E Mattison1, Victoria Rundberg-Rivera, Chenel Michel.   

Abstract

OBJECTIVE: Characteristics of psychotropic medication use have rarely been investigated for special education students with emotional and/or behavioral disorders.
METHODS: The prevalence of psychotropic medication use was obtained at the beginning of a school year for a cohort of 77 students attending a self-contained middle school for special education students with emotional and/or behavioral problems, in the suburban New York City area. Demographics, intelligence quotient (IQ) and achievement testing, and objective measures of both psychopathology and school functioning were gathered.
RESULTS: Overall, psychotropic medication was used in 77.9% of the participants; 52.0% received more than one medication. The most commonly prescribed medicines were atypical antipsychotics (49.4%) followed by attention-deficit/hyperactivity disorder (ADHD) medications (48.0%). Usage patterns for specific diagnostic presentations were examined, and appeared consistent with current clinical practice. Persistent elevated psychopathology appeared frequently in students on medication.
CONCLUSIONS: Psychotropic medication use in this unique but important sample of special education students appeared generally consistent with recent psychotropic prevalence research. The need for collaboration between special education teachers and prescribing physicians, in order to achieve optimal medication adjustment for these students, was highlighted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24506802      PMCID: PMC4137357          DOI: 10.1089/cap.2013.0073

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  13 in total

1.  Psychotropic practice patterns for youth: a 10-year perspective.

Authors:  Julie Magno Zito; Daniel J Safer; Susan DosReis; James F Gardner; Laurence Magder; Karen Soeken; Myde Boles; Frances Lynch; Mark A Riddle
Journal:  Arch Pediatr Adolesc Med       Date:  2003-01

Review 2.  Practice parameter for the assessment and treatment of children and adolescents with schizophrenia.

Authors:  Jon McClellan; Saundra Stock
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-09       Impact factor: 8.829

3.  Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD.

Authors:  Joseph C Blader; Steven R Pliszka; Peter S Jensen; Nina R Schooler; Vivian Kafantaris
Journal:  Pediatrics       Date:  2010-09-13       Impact factor: 7.124

4.  National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Authors:  Jonathan S Comer; Mark Olfson; Ramin Mojtabai
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

5.  National trends in the use of psychotropic medications by children.

Authors:  Mark Olfson; Steven C Marcus; Myrna M Weissman; Peter S Jensen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-05       Impact factor: 8.829

6.  Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York.

Authors:  Jud A Staller; Michael J Wade; Molly Baker
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-02       Impact factor: 2.576

7.  Concomitant pharmacotherapy among youths treated in routine psychiatric practice.

Authors:  Farifteh Firoozmand Duffy; William E Narrow; Donald S Rae; Joyce C West; Deborah A Zarin; Maritza Rubio-Stipec; Harold Alan Pincus; Darrel A Regier
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-02       Impact factor: 2.576

8.  A DSM-IV-referenced teacher rating scale for use in clinical management.

Authors:  Richard E Mattison; Kenneth D Gadow; Joyce Sprafkin; Edith E Nolan; Jayne Schneider
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-04       Impact factor: 8.829

9.  Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.

Authors:  Julie Magno Zito; Mehmet Burcu; Aloysius Ibe; Daniel J Safer; Laurence S Magder
Journal:  Psychiatr Serv       Date:  2013-03-01       Impact factor: 3.084

10.  National trends in the office-based treatment of children, adolescents, and adults with antipsychotics.

Authors:  Mark Olfson; Carlos Blanco; Shang-Min Liu; Shuai Wang; Christoph U Correll
Journal:  Arch Gen Psychiatry       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.